These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19578178)

  • 1. Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.
    Bergval IL; Schuitema AR; Klatser PR; Anthony RM
    J Antimicrob Chemother; 2009 Sep; 64(3):515-23. PubMed ID: 19578178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
    Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
    J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.
    Dalla Costa ER; Ribeiro MO; Silva MS; Arnold LS; Rostirolla DC; Cafrune PI; Espinoza RC; Palaci M; Telles MA; Ritacco V; Suffys PN; Lopes ML; Campelo CL; Miranda SS; Kremer K; da Silva PE; Fonseca Lde S; Ho JL; Kritski AL; Rossetti ML
    BMC Microbiol; 2009 Feb; 9():39. PubMed ID: 19228426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations.
    Lempens P; Meehan CJ; Vandelannoote K; Fissette K; de Rijk P; Van Deun A; Rigouts L; de Jong BC
    Sci Rep; 2018 Feb; 8(1):3246. PubMed ID: 29459669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona.
    Coll P; Aragón LM; Alcaide F; Espasa M; Garrigó M; González J; Manterola JM; Orús P; Salvadó M
    Microb Drug Resist; 2005; 11(2):107-14. PubMed ID: 15910223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
    Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
    Narmandakh E; Tumenbayar O; Borolzoi T; Erkhembayar B; Boldoo T; Dambaa N; Burneebaatar B; Nymadawa N; Mitarai S; Jav S; Chiang CY
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.
    Aragón LM; Navarro F; Heiser V; Garrigó M; Español M; Coll P
    J Antimicrob Chemother; 2006 May; 57(5):825-31. PubMed ID: 16547071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR.
    Hristea A; Otelea D; Paraschiv S; Macri A; Baicus C; Moldovan O; Tinischi M; Arama V; Streinu-Cercel A
    Indian J Med Microbiol; 2010; 28(3):211-6. PubMed ID: 20644308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey.
    Ozturk CE; Sanic A; Kaya D; Ceyhan I
    Jpn J Infect Dis; 2005 Oct; 58(5):309-12. PubMed ID: 16249627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in rpoB, katG and inhA mutations between new and previously treated tuberculosis cases using the GenoType MTBDRplus assay.
    Alvarez-Uria G; Reddy R
    Infect Genet Evol; 2018 Apr; 59():48-50. PubMed ID: 29413885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
    Yao C; Zhu T; Li Y; Zhang L; Zhang B; Huang J; Fu W
    Clin Microbiol Infect; 2010 Nov; 16(11):1639-43. PubMed ID: 20491829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
    Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam.
    Caws M; Duy PM; Tho DQ; Lan NT; Hoa DV; Farrar J
    J Clin Microbiol; 2006 Jul; 44(7):2333-7. PubMed ID: 16825345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.